3D Kidney Model Education for Kidney Disease
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the 3D Kidney Model treatment for kidney disease?
How is the 3D Kidney Model treatment different from other treatments for kidney disease?
What is the purpose of this trial?
High blood pressure has a different rate effect on many minoritized individuals. African Americans, as a result of high blood pressure, are six times more likely to go through kidney failure compared to white counterparts. Hispanic communities are also disproportionately affected by high blood pressure and, unfortunately, generally have lower knowledge about the effects on the kidneys as well. Unfortunately, many minoritized and underserved communities are affected by the weight of the social determinants of health, i.e., housing, education, food, health care, etc., that contribute to large disparities in health outcomes. These factors lead to poor care management, less ability to manage care effectively, and disengagement from care. Health education is vital to recognizing and communicating with minoritized patients with hypertension-induced chronic renal disease. As the patient's knowledge of the condition grows, this can significantly influence the trust between clinicians and patients. Effective and patient-centered education can inspire patients to be proactive in their prevention strategies with clinicians. This study's overall goal is to assess the utility of a novel patient education tool (3D-printed healthy kidney and diseased kidney models) in optimizing patient education for underserved populations who have hypertension with a potential lead to hypertension-induced chronic renal disease.
Research Team
Hilary L Surratt, PhD
Principal Investigator
University of Kentucky
Eligibility Criteria
This trial is for individuals from minoritized communities with high blood pressure that may lead to chronic kidney disease. It aims to educate those who might not have extensive knowledge about the impact of hypertension on kidneys, focusing on African American and Hispanic populations affected by health disparities.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive patient education using either standard clinician-led methods or the 3D kidney model
Follow-up
Participants are monitored for changes in understanding and confidence in managing kidney disease
Treatment Details
Interventions
- 3D Kidney Model
Find a Clinic Near You
Who Is Running the Clinical Trial?
Hilary L Surratt, PhD
Lead Sponsor
University of Kentucky
Collaborator